Abstract P4-13-20: Activity of HP-based therapies as third and later lines for the treatment of HER2-positive metastatic breast cancer: A retrospective study from a single institution
Keyword(s):
Keyword(s):
Keyword(s):
2010 ◽
Vol 28
(15_suppl)
◽
pp. 1145-1145
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 33
(15_suppl)
◽
pp. 616-616
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):